{"id":64540,"date":"2026-05-06T20:36:17","date_gmt":"2026-05-06T12:36:17","guid":{"rendered":"https:\/\/flcube.com\/?p=64540"},"modified":"2026-05-06T20:36:19","modified_gmt":"2026-05-06T12:36:19","slug":"chinas-nhc-establishes-regulatory-framework-for-biomedical-new-technologies-with-interim-guiding-principles-effective-may-1-2026","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=64540","title":{"rendered":"China&#8217;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026"},"content":{"rendered":"\n<p>The <strong>National Health Commission (NHC)<\/strong> of China has implemented the <strong>Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim)<\/strong>, effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-framework-overview\">Regulatory Framework Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Effective Date<\/strong><\/td><td>May 1, 2026<\/td><\/tr><tr><td><strong>Primary Focus<\/strong><\/td><td>Technologies difficult to develop as medical devices or drugs<\/td><\/tr><tr><td><strong>Target Technologies<\/strong><\/td><td>Highly innovative, highly personalized biomedical approaches<\/td><\/tr><tr><td><strong>Regulatory Approach<\/strong><\/td><td>Clinical research filing system with safety baseline requirements<\/td><\/tr><tr><td><strong>Implementation Mechanism<\/strong><\/td><td>Guiding Principles-List for Clinical Research Filing<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The framework acknowledges the rapid evolution of biomedical new technologies and the considerable uncertainty surrounding their future clinical translation and application, while balancing regulatory oversight with innovation support.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-classification-amp-compliance-requirements\">Classification &amp; Compliance Requirements<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Biomedical New Technologies:<\/strong> Must follow standardized technical names and filing requirements in the Filing Guidance List<\/li>\n\n\n\n<li><strong>Drugs\/Medical Devices:<\/strong> Continue to be regulated under existing drug and device laws<\/li>\n\n\n\n<li><strong>Filing Documentation:<\/strong> Complete submission required for timely compliance<\/li>\n\n\n\n<li><strong>Clinical Data Utility:<\/strong> Filing-based research data can support future clinical translation and application<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-five-core-principles-for-inclusion\">Five Core Principles for Inclusion<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Principle<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Legal &amp; Regulatory Compliance<\/strong><\/td><td>Adherence to existing Chinese regulatory frameworks<\/td><\/tr><tr><td><strong>Clear Medical Purpose<\/strong><\/td><td>Defined therapeutic or diagnostic intent<\/td><\/tr><tr><td><strong>Clear Mechanistic Rationale<\/strong><\/td><td>Scientifically sound biological mechanism<\/td><\/tr><tr><td><strong>Sufficient Preliminary Evidence<\/strong><\/td><td>Robust preclinical or early clinical data<\/td><\/tr><tr><td><strong>Not Yet Clinically Applied<\/strong><\/td><td>Novel technologies without established clinical use<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-initial-filing-guidance-list-coverage\">Initial Filing Guidance List Coverage<\/h2>\n\n\n\n<p>The first edition of the Filing Guidance List encompasses five major categories of emerging biomedical technologies:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>New gene therapy technologies<\/strong><\/li>\n\n\n\n<li><strong>New cell and derivative therapy technologies<\/strong><\/li>\n\n\n\n<li><strong>New tissue and organ therapy technologies<\/strong><\/li>\n\n\n\n<li><strong>New microbial therapy technologies<\/strong><\/li>\n\n\n\n<li><strong>New brain-computer interface technologies<\/strong><\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-impact-amp-industry-implications\">Strategic Impact &amp; Industry Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Clarity:<\/strong> Provides much-needed classification guidance for cutting-edge therapies that don&#8217;t fit traditional regulatory boxes<\/li>\n\n\n\n<li><strong>Innovation Support:<\/strong> Enables clinical research while maintaining safety standards through structured filing requirements<\/li>\n\n\n\n<li><strong>Dynamic Framework:<\/strong> NHC commits to regularly updating the Filing Guidance List based on technological advances and clinical needs<\/li>\n\n\n\n<li><strong>Global Alignment:<\/strong> Represents China&#8217;s effort to establish modern regulatory pathways comparable to international advanced therapy frameworks<\/li>\n\n\n\n<li><strong>Investment Confidence:<\/strong> Clear regulatory pathways may attract increased R&amp;D investment in China&#8217;s advanced therapy sector<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory implementation and industry impact. Actual outcomes may differ due to evolving regulatory interpretations, policy adjustments, and market dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-44fba607-0a27-4a23-9964-b749065f492a\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/\u751f\u7269\u533b\u5b66\u65b0\u6280\u672f\u4e34\u5e8a\u7814\u7a76\u5907\u6848\u6307\u5bfc\u6e05\u5355\uff08\u7b2c1\u7248\uff09.docx\">\u751f\u7269\u533b\u5b66\u65b0\u6280\u672f\u4e34\u5e8a\u7814\u7a76\u5907\u6848\u6307\u5bfc\u6e05\u5355\uff08\u7b2c1\u7248\uff09<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/\u751f\u7269\u533b\u5b66\u65b0\u6280\u672f\u4e34\u5e8a\u7814\u7a76\u5907\u6848\u6307\u5bfc\u6e05\u5355\uff08\u7b2c1\u7248\uff09.docx\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-44fba607-0a27-4a23-9964-b749065f492a\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[60],"class_list":["post-64540","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhc-nhfpc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026 - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=64540\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026\" \/>\n<meta property=\"og:description\" content=\"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=64540\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T12:36:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-06T12:36:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026\",\"datePublished\":\"2026-05-06T12:36:17+00:00\",\"dateModified\":\"2026-05-06T12:36:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540\"},\"wordCount\":400,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHC (NHFPC)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64540#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=64540\",\"name\":\"China's NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026 - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-06T12:36:17+00:00\",\"dateModified\":\"2026-05-06T12:36:19+00:00\",\"description\":\"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64540\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64540#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026 - Insight, China&#039;s Pharmaceutical Industry","description":"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=64540","og_locale":"en_US","og_type":"article","og_title":"China's NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026","og_description":"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.","og_url":"https:\/\/flcube.com\/?p=64540","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-06T12:36:17+00:00","article_modified_time":"2026-05-06T12:36:19+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=64540#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=64540"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026","datePublished":"2026-05-06T12:36:17+00:00","dateModified":"2026-05-06T12:36:19+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=64540"},"wordCount":400,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHC (NHFPC)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=64540#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=64540","url":"https:\/\/flcube.com\/?p=64540","name":"China's NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026 - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-06T12:36:17+00:00","dateModified":"2026-05-06T12:36:19+00:00","description":"The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical New Technologies vs. Drugs and Medical Devices (Interim), effective May 1, 2026, establishing a comprehensive regulatory framework for emerging biomedical innovations that fall outside traditional drug and device classifications.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=64540#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=64540"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=64540#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64540"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64540\/revisions"}],"predecessor-version":[{"id":64542,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64540\/revisions\/64542"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}